Alexion pharmaceuticals, inc. (ALXN)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08
Contract research revenues

-

-

-

-

-

-

-

-

-

-

-

0

Total revenues

4,991

4,131

3,551

3,084

2,604

2,234

1,551

-

-

-

-

259

Cost of sales:
Cost of sales (exclusive of amortization of purchased intangible assets)

394

374

454

258

233

174

168

126

93

64

45

28

Gain on intellectual property settlement

-

-

-

-

-

-

-

-

-

0

-

-

Change in contingent liability from intellectual property settlements

-

-

-

-

-

-

-9

53

0

-

-

-

Total cost of sales

-

-

-

-

-

-

177

72

93

64

-

-

Research and development

886

730

878

757

709

514

317

222

137

98

81

62

Selling, general and administrative

1,261

1,111

1,094

953

862

630

489

384

308

226

172

133

Research and Development Asset Acquired Other than Through Business Combination, Written-off

-4

1,183

0

0

-

-

-

-

-

-

-

-

Amortization of purchased intangible assets

309

320

320

322

116

0

0

0

0

0

0

-

Change in fair value of contingent consideration

11

116

41

35

64

20

4

-

-

-

-

-

Acquisition-related costs

-

-

-

2

39

0

1

22

13

0

0

-

Restructuring expenses

12

25

104

3

42

15

0

0

-

-

-

-

Impairment of intangible assets

0

0

31

85

0

12

33

26

0

0

-

-

Total operating expenses

2,476

3,487

2,469

2,158

1,834

1,191

845

656

459

325

254

196

Operating income

2,120

269

627

667

536

869

528

404

230

150

87

34

Other income and expense:
Investment (expense) income

100

65

18

10

8

8

3

1

1

1

0

2

Interest expense

77

98

98

96

47

3

4

7

0

0

0

2

Other income and (expense)

35

5

0

-5

0

-2

-0

-1

-2

-2

-0

-0

Debt exchange expense

-

-

-

-

-

-

-

-

-

-

3

-

Income before income taxes

2,178

242

547

576

498

872

526

397

229

149

83

34

Income tax expense (benefit)

-225

164

104

176

353

215

273

142

54

51

-211

1

Net income

2,404

77

443

399

144

657

252

254

175

97

295

33

Earnings per common share
Basic

10.77

0.35

1.98

1.78

0.68

3.32

1.29

1.34

0.96

0.54

1.73

0.43

Diluted

10.70

0.35

1.97

1.76

0.67

3.26

1.27

1.28

0.91

0.52

1.63

0.39

Shares used in computing earnings per common share
Basic

223

222

223

224

213

198

195

190

183

178

170

77

Diluted

224

224

225

226

215

202

199

198

191

186

181

89

Net Product Sales
Total revenues

4,990

4,130

3,549

3,081

2,602

2,234

1,551

1,134

783

540

386

259

Other Revenue
Total revenues

1

1

1

2

1

0

0

-

-

-

-

-